276 related articles for article (PubMed ID: 31736980)
1. OLT1177 (Dapansutrile), a Selective NLRP3 Inflammasome Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis.
Sánchez-Fernández A; Skouras DB; Dinarello CA; López-Vales R
Front Immunol; 2019; 10():2578. PubMed ID: 31736980
[TBL] [Abstract][Full Text] [Related]
2. The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer's disease.
Lonnemann N; Hosseini S; Marchetti C; Skouras DB; Stefanoni D; D'Alessandro A; Dinarello CA; Korte M
Proc Natl Acad Sci U S A; 2020 Dec; 117(50):32145-32154. PubMed ID: 33257576
[TBL] [Abstract][Full Text] [Related]
3. OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation.
Marchetti C; Swartzwelter B; Gamboni F; Neff CP; Richter K; Azam T; Carta S; Tengesdal I; Nemkov T; D'Alessandro A; Henry C; Jones GS; Goodrich SA; St Laurent JP; Jones TM; Scribner CL; Barrow RB; Altman RD; Skouras DB; Gattorno M; Grau V; Janciauskiene S; Rubartelli A; Joosten LAB; Dinarello CA
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1530-E1539. PubMed ID: 29378952
[TBL] [Abstract][Full Text] [Related]
4. NLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of acute arthritis.
Marchetti C; Swartzwelter B; Koenders MI; Azam T; Tengesdal IW; Powers N; de Graaf DM; Dinarello CA; Joosten LAB
Arthritis Res Ther; 2018 Aug; 20(1):169. PubMed ID: 30075804
[TBL] [Abstract][Full Text] [Related]
5. Nicotinamide adenine dinucleotide treatment alleviates the symptoms of experimental autoimmune encephalomyelitis by activating autophagy and inhibiting the NLRP3 inflammasome.
Wang X; Li B; Liu L; Zhang L; Ma T; Guo L
Int Immunopharmacol; 2021 Jan; 90():107092. PubMed ID: 33290962
[TBL] [Abstract][Full Text] [Related]
6. The NLRP3 Inflammasome Inhibitor, OLT1177 (Dapansutrile), Reduces Infarct Size and Preserves Contractile Function After Ischemia Reperfusion Injury in the Mouse.
Toldo S; Mauro AG; Cutter Z; Van Tassell BW; Mezzaroma E; Del Buono MG; Prestamburgo A; Potere N; Abbate A
J Cardiovasc Pharmacol; 2019 Apr; 73(4):215-222. PubMed ID: 30747785
[TBL] [Abstract][Full Text] [Related]
7. Preservation of Contractile Reserve and Diastolic Function by Inhibiting the NLRP3 Inflammasome with OLT1177
Aliaga J; Bonaventura A; Mezzaroma E; Dhakal Y; Mauro AG; Abbate A; Toldo S
Molecules; 2021 Jun; 26(12):. PubMed ID: 34207886
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the NLRP3 inflammasome by OLT1177 induces functional protection and myelin preservation after spinal cord injury.
Amo-Aparicio J; Garcia-Garcia J; Puigdomenech M; Francos-Quijorna I; Skouras DB; Dinarello CA; Lopez-Vales R
Exp Neurol; 2022 Jan; 347():113889. PubMed ID: 34624330
[TBL] [Abstract][Full Text] [Related]
9. Sinomenine Alleviates Murine Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis through Inhibiting NLRP3 Inflammasome.
Kiasalari Z; Afshin-Majd S; Baluchnejadmojarad T; Azadi-Ahmadabadi E; Fakour M; Ghasemi-Tarie R; Jalalzade-Ogvar S; Khodashenas V; Tashakori-Miyanroudi M; Roghani M
J Mol Neurosci; 2021 Feb; 71(2):215-224. PubMed ID: 32812186
[TBL] [Abstract][Full Text] [Related]
10. 1,2,4-Trimethoxybenzene selectively inhibits NLRP3 inflammasome activation and attenuates experimental autoimmune encephalomyelitis.
Pan RY; Kong XX; Cheng Y; Du L; Wang ZC; Yuan C; Cheng JB; Yuan ZQ; Zhang HY; Liao YJ
Acta Pharmacol Sin; 2021 Nov; 42(11):1769-1779. PubMed ID: 33627802
[TBL] [Abstract][Full Text] [Related]
11. NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses.
Gris D; Ye Z; Iocca HA; Wen H; Craven RR; Gris P; Huang M; Schneider M; Miller SD; Ting JP
J Immunol; 2010 Jul; 185(2):974-81. PubMed ID: 20574004
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype.
Hou B; Zhang Y; Liang P; He Y; Peng B; Liu W; Han S; Yin J; He X
Cell Death Dis; 2020 May; 11(5):377. PubMed ID: 32415059
[TBL] [Abstract][Full Text] [Related]
13. Development and Characterization of a Hydroxyl-Sulfonamide Analogue, 5-Chloro-N-[2-(4-hydroxysulfamoyl-phenyl)-ethyl]-2-methoxy-benzamide, as a Novel NLRP3 Inflammasome Inhibitor for Potential Treatment of Multiple Sclerosis.
Guo C; Fulp JW; Jiang Y; Li X; Chojnacki JE; Wu J; Wang XY; Zhang S
ACS Chem Neurosci; 2017 Oct; 8(10):2194-2201. PubMed ID: 28653829
[TBL] [Abstract][Full Text] [Related]
14. Inflammasome activation in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE).
Barclay W; Shinohara ML
Brain Pathol; 2017 Mar; 27(2):213-219. PubMed ID: 27997058
[TBL] [Abstract][Full Text] [Related]
15. Activating cannabinoid receptor 2 alleviates pathogenesis of experimental autoimmune encephalomyelitis via activation of autophagy and inhibiting NLRP3 inflammasome.
Shao BZ; Wei W; Ke P; Xu ZQ; Zhou JX; Liu C
CNS Neurosci Ther; 2014 Dec; 20(12):1021-8. PubMed ID: 25417929
[TBL] [Abstract][Full Text] [Related]
16. Ellagic acid ameliorates neuroinflammation and demyelination in experimental autoimmune encephalomyelitis: Involvement of NLRP3 and pyroptosis.
Kiasalari Z; Afshin-Majd S; Baluchnejadmojarad T; Azadi-Ahmadabadi E; Esmaeil-Jamaat E; Fahanik-Babaei J; Fakour M; Fereidouni F; Ghasemi-Tarie R; Jalalzade-Ogvar S; Khodashenas V; Sanaierad A; Zahedi E; Roghani M
J Chem Neuroanat; 2021 Jan; 111():101891. PubMed ID: 33217488
[TBL] [Abstract][Full Text] [Related]
17. Potential role of BAY11-7082, a NF-κB blocker inhibiting experimental autoimmune encephalomyelitis in C57BL/6J mice via declining NLRP3 inflammasomes.
Lang Y; Chu F; Liu L; Zheng C; Li C; Shen D; Liu S; Zhang W; Cui L; Zhu J
Clin Exp Immunol; 2022 May; 207(3):378-386. PubMed ID: 35553640
[TBL] [Abstract][Full Text] [Related]
18. An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
Choi JH; Lee MJ; Jang M; Kim EJ; Shim I; Kim HJ; Lee S; Lee SW; Kim YO; Cho IH
PLoS One; 2015; 10(10):e0138592. PubMed ID: 26444423
[TBL] [Abstract][Full Text] [Related]
19. AZD8055 ameliorates experimental autoimmune encephalomyelitis via the mTOR/ROS/NLRP3 pathway.
He M; Wu DM; Zhao YY; Yu Y; Deng SH; Liu T; Zhang T; Li J; Wang F; Xu Y
Biochem Biophys Res Commun; 2021 Oct; 573():27-34. PubMed ID: 34384953
[TBL] [Abstract][Full Text] [Related]
20. The NLRP3 inhibitor, OLT1177 attenuates brain injury in experimental intracerebral hemorrhage.
Fang M; Xia F; Wang J; Wang C; Teng B; You S; Li M; Chen X; Hu X
Int Immunopharmacol; 2024 Apr; 131():111869. PubMed ID: 38492343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
